When to pause or stop Most side effects resolve with time and do not require protocol changes
Both routes demonstrate excellent safety profiles in available studies
For BPC-157, this means introducing bacteriostatic water into the sealed vial, allowing the powder to fully dissolve, and producing a stable solution that maintains the peptides structural integrity throughout the research protocol
Low B12 levels can cause fatigue, weakness, shortness of breath, headaches, digestive changes, and other symptoms
As an pro-angiogenic agent, it's theoretically possible for BPC-157 to enable cancers to grow
As the debate raged on, other studies investigated the potential of hydroxychloroquine as a COVID treatment and failed to see any benefit